SITC Guidelines News Community Blog

Back to SITC Cancer Immunotherapy Guidelines

ICI-Related Adverse Events CPG Updates v1.1 and v1.2 Now Available

posted 8 days ago
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, ...
0 comments

Urothelial Cancer CPG Update v2.3 Now Available

posted 14 days ago
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, ...
0 comments

Melanoma CPG Update v3.1 Now Available

posted 29 days ago
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, ...
0 comments

Gynecologic Cancer CPG Update v1.1 Now Available

posted 06-20-2024
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, ...
0 comments

Breast Cancer CPG Update v1.2 Now Available

posted 06-03-2024
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, ...
0 comments

SITC Living Guidelines – Rapid Updates to Published Clinical Practice Guidelines

posted 05-23-2024
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, ...
0 comments

Nonmelanoma Skin Cancer CPG Update v1.1 Now Available

posted 03-19-2024
In accordance with the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs), SITC CPGs undergo periodic evaluation to assess if new evidence necessitates modifications to recommendations, ...
0 comments

New SITC Melanoma CPG Published in JITC

posted 10-18-2023
On behalf of the Society for Immunotherapy of Cancer (SITC) and the SITC Melanoma Guideline Expert Panel, we are pleased to announce the publication of SITC’s Melanoma Clinical Practice Guideline (CPG), version 3.0. This ...
0 comments

New SITC Gynecologic Cancer CPG Published in JITC

posted 06-09-2023
On behalf of the Society for Immunotherapy of Cancer (SITC) and the SITC Gynecologic Cancer Immunotherapy Guideline Expert Panel, we are pleased to announce the publication of SITC’s Gynecologic Cancer Clinical Practice ...
0 comments

New SITC Gastrointestinal Cancer CPG Published in JITC

posted 06-07-2023
SITC is pleased to announce the publication of our newest guideline, " Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer. " Clinicians ...
0 comments

Open Comment Period for SITC’s Melanoma Guideline Closes March 16

posted 02-23-2023
The Society for Immunotherapy of Cancer (SITC) Melanoma Immunotherapy Guideline Expert Panel is pleased to invite public comment on the draft clinical practice guideline (CPG) “Society for Immunotherapy of Cancer (SITC) clinical ...
0 comments

Open Comment Periods for SITC’s Gynecologic Cancer and Gastrointestinal Cancer Guidelines Close January 27

posted 01-12-2023
The Society for Immunotherapy of Cancer (SITC) is pleased to invite public comment on two new draft clinical practice guidelines (CPGs): “Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy ...
0 comments

Help SITC Performance Test Our Next Quality Measure – Apply by January 5

posted 12-20-2022
The Society for Immunotherapy of Cancer (SITC) is currently recruiting practices for clinician-level testing of the draft quality measure: Positive PD-L1 Biomarker Expression Test Result Prior to First-Line Immune Checkpoint ...
0 comments

New Interactive Tools for SITC’s Nonmelanoma Skin Cancer and Lung Cancer & Mesothelioma Guidelines

posted 11-15-2022
New interactive tools have been developed and integrated into the SITC CPG Mobile App for two of SITC’s guidelines that published in 2022. An overview of the guideline content as well as a highlight of the new tools and ...
0 comments

New Guideline Information and Tools Available – Lymphoma, RCC, ICI-rAEs, Urothelial Cancer & Prostate Cancer

posted 11-09-2022
Previously published guidelines have new and updated content available only in the app. Below is an overview of the guidelines for which updates are available. A full description of the event that prompted the update as well ...
0 comments

New SITC Nonmelanoma Skin Cancer CPG Published in JITC

posted 07-28-2022
SITC is pleased to announce the publication of our newest guideline, "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer." Clinicians will ...
0 comments

New SITC Lung Cancer and Mesothelioma CPG Published in JITC

posted 05-31-2022
SITC is pleased to announce the publication of our newest guideline, " Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma . " This ...
0 comments

SITC Cancer Immunotherapy Guidelines Mini Modules

posted 03-16-2022
SITC is pleased to announce a new educational offering for the society’s clinical practice guidelines – SITC’s Cancer Immunotherapy Guidelines Mini Modules. Designed for practitioners with a desire to learn but with limited ...
0 comments

SITC Cancer Immunotherapy Guidelines Webinars

posted 03-11-2022
SITC’s Cancer Immunotherapy Guidelines Webinars connect clinicians with leading experts in the field and provide education about the evidence- and consensus-based recommendations in the clinical practice guidelines. On-demand ...
0 comments

SITC CPG Mobile App Update – Multiple Myeloma Guideline: D-Kd PLEIADES data and FDA approval

posted 02-01-2022
The SITC Multiple Myeloma Expert Panel has updated the guidelines content and recommendations based on the November 30, 2021 FDA approval of daratumumab in combination with carfilzomib and dexamethasone (D-Kd) for adult patients ...
0 comments